Fig. 1
From: Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results
CONSORT diagram of MagnetisMM-3.
Fig. 1 | Nature Medicine
From: Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results
CONSORT diagram of MagnetisMM-3.
